Sartorius Stedim Biotech S.A. (FRA:56S1)

Sartorius Stedim Biotech Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,947	2,780	2,776	3,493	2,887	1,910
Revenue Growth (YoY)	7.72%	0.16%	-20.53%	20.98%	51.14%	32.59%
Cost of Revenue	1,602	1,573	1,542	1,675	1,334	906.76
Gross Profit	1,345	1,207	1,234	1,817	1,553	1,003
Selling, General & Admin	666.7	650.1	617.6	612.3	531.9	391.85
Research & Development	138.5	144.1	129.5	132.4	110.5	84.45
Other Operating Expenses	24.1	16.5	17.5	18.2	-9.6	23.89
Operating Expenses	829.3	810.7	764.6	762.9	632.8	500.19
Operating Income	515.4	396	469.4	1,054	920.2	503.14
Interest Expense	-155.3	-148	-115.4	-18.2	-10.2	-6.51
Interest & Investment Income	24	18.9	6.2	0.5	0.3	0.51
Earnings From Equity Investments	-8.6	-8.6	-	-	-	-
Currency Exchange Gain (Loss)	6.6	6.6	-13.3	-32.8	12.3	-14.66
Other Non Operating Income (Expenses)	-12.9	-12.9	-4.3	-4.6	-37.1	1.08
EBT Excluding Unusual Items	369.2	252	342.6	999.3	885.5	483.55
Merger & Restructuring Charges	-	-	-	-	-20.3	-4.3
Other Unusual Items	-32.8	-32.8	59.3	131.1	-218.5	-18.56
Pretax Income	336.4	219.2	401.9	1,130	646.7	460.69
Income Tax Expense	71.4	40.7	89.2	250.5	232.4	122.1
Earnings From Continuing Operations	265	178.5	312.7	879.9	414.3	338.6
Minority Interest in Earnings	-1.1	-3.4	-2.4	-3.8	0.1	-2.67
Net Income	263.9	175.1	310.3	876.1	414.4	335.93
Net Income to Common	263.9	175.1	310.3	876.1	414.4	335.93
Net Income Growth	64.32%	-43.57%	-64.58%	111.41%	23.36%	43.25%
Shares Outstanding (Basic)	97	97	92	92	92	92
Shares Outstanding (Diluted)	97	97	92	92	92	92
Shares Change (YoY)	2.03%	5.01%	-0.00%	-0.01%	-0.00%	0.00%
EPS (Basic)	2.71	1.81	3.37	9.51	4.50	3.64
EPS (Diluted)	2.71	1.81	3.37	9.51	4.50	3.64
EPS Growth	61.10%	-46.26%	-64.58%	111.45%	23.51%	43.31%
Free Cash Flow	374.5	475.3	272.8	181.7	377.9	257.69
Free Cash Flow Per Share	3.85	4.91	2.96	1.97	4.10	2.79
Dividend Per Share	-	0.690	0.690	1.440	1.260	0.680
Dividend Growth	-	-	-52.08%	14.29%	85.29%	100.00%
Gross Margin	45.64%	43.41%	44.46%	52.03%	53.79%	52.53%
Operating Margin	17.49%	14.24%	16.91%	30.19%	31.87%	26.34%
Profit Margin	8.96%	6.30%	11.18%	25.08%	14.35%	17.59%
Free Cash Flow Margin	12.71%	17.10%	9.83%	5.20%	13.09%	13.49%
EBITDA	761.8	629.3	657.7	1,197	1,031	577.32
EBITDA Margin	25.85%	22.64%	23.70%	34.27%	35.73%	30.23%
D&A For EBITDA	246.4	233.3	188.3	142.5	111.2	74.18
EBIT	515.4	396	469.4	1,054	920.2	503.14
EBIT Margin	17.49%	14.24%	16.91%	30.19%	31.87%	26.34%
Effective Tax Rate	21.22%	18.57%	22.20%	22.16%	35.94%	26.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.